We are live on ! Find out more
CCP

Corient Capital Partners Portfolio holdings

AUM $1.34B
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
-12.07%
1 Year Est. Return
-12.46%
3 Year Est. Return
+39.22%
5 Year Est. Return
+66.79%
10 Year Est. Return
AUM
$561M
AUM Growth
-$39.7M
Cap. Flow
+$40.3M
Cap. Flow %
7.18%
Top 10 Hldgs %
31.65%
Holding
327
New
69
Increased
109
Reduced
108
Closed
28

Sector Composition

Rank Sector Weight
1 Healthcare 10.38%
2 Financials 10.27%
3 Technology 9.96%
4 Consumer Discretionary 7.58%
5 Industrials 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBY icon
76
Best Buy
BBY
$18.9B
$2M 0.36%
37,794
+689
+2% +$45K
OXY icon
77
Occidental Petroleum
OXY
$53.6B
$1.99M 0.35%
32,357
-10,979
-25% -$772K
META icon
78
Meta Platforms (Facebook)
META
$1.51T
$1.98M 0.35%
15,088
+5,222
+53% +$757K
MMM icon
79
3M
MMM
$94.1B
$1.97M 0.35%
12,353
+1,422
+13% +$236K
XLF icon
80
State Street Financial Select Sector SPDR ETF
XLF
$57.4B
$1.94M 0.35%
+81,505
New +$2.12M
GOOGL icon
81
Alphabet (Google) Class A
GOOGL
$4.08T
$1.94M 0.34%
37,040
+12,360
+50% +$668K
KMB icon
82
Kimberly-Clark
KMB
$37.5B
$1.92M 0.34%
16,826
-10,495
-38% -$1.16M
UNH icon
83
UnitedHealth
UNH
$389B
$1.91M 0.34%
7,652
+2,803
+58% +$740K
CAH icon
84
Cardinal Health
CAH
$54.5B
$1.9M 0.34%
+42,527
New +$2.22M
DISCK
85
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$1.9M 0.34%
82,201
-39,975
-33% -$1.11M
GILD icon
86
Gilead Sciences
GILD
$167B
$1.88M 0.33%
29,972
-12,054
-29% -$843K
VIAB
87
DELISTED
Viacom Inc. Class B
VIAB
$1.83M 0.33%
71,190
-24,842
-26% -$765K
AVGO icon
88
Broadcom
AVGO
$1.81T
$1.82M 0.32%
71,640
-1,100
-2% -$26K
DINO icon
89
HF Sinclair
DINO
$16.1B
$1.81M 0.32%
+35,366
New +$2.17M
IWO icon
90
iShares Russell 2000 Growth ETF
IWO
$14.4B
$1.81M 0.32%
10,749
-250
-2% -$46.6K
QQQ icon
91
Invesco QQQ Trust
QQQ
$445B
$1.77M 0.32%
11,491
+47
+0.4% +$7.86K
LEN icon
92
Lennar Class A
LEN
$21.1B
$1.76M 0.31%
46,551
-28,649
-38% -$1.17M
VOT icon
93
Vanguard Mid-Cap Growth ETF
VOT
$19.1B
$1.76M 0.31%
14,738
-2,062
-12% -$265K
AZN icon
94
AstraZeneca
AZN
$267B
$1.74M 0.31%
22,936
-20,519
-47% -$1.6M
SYF icon
95
Synchrony
SYF
$25.1B
$1.73M 0.31%
73,723
+356
+0.5% +$9.63K
V icon
96
Visa
V
$697B
$1.71M 0.3%
12,958
+5,356
+70% +$740K
VT icon
97
Vanguard Total World Stock ETF
VT
$76.3B
$1.71M 0.3%
26,111
+22,261
+578% +$1.56M
GOOG icon
98
Alphabet (Google) Class C
GOOG
$4.07T
$1.7M 0.3%
32,920
+12,460
+61% +$667K
PPG icon
99
PPG Industries
PPG
$26.5B
$1.69M 0.3%
16,515
+849
+5% +$87.9K
MDLZ icon
100
Mondelez International
MDLZ
$80.2B
$1.68M 0.3%
41,893
+13,291
+46% +$567K

Similar funds

Corient Capital Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Corient Capital Partners held 327 positions worth $561M, down 6.6% from $601M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Corient Capital Partners deployed $40.3M of net new capital in Q4 2018, opening 69 new positions and adding to 109 existing holdings. Its largest new stake was Vanguard High Dividend Yield ETF: 110,486 shares worth $8.62M.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, up from 10% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Vanguard S&P 500 Growth ETF, an estimated $6.14M trimmed.

  • Corient Capital Partners's largest Q4 2018 buy was Vanguard High Dividend Yield ETF: 110,486 shares worth $8.62M.
  • Corient Capital Partners added most to Vanguard Value ETF in Q4 2018, an estimated $12.8M increase.
  • Corient Capital Partners's biggest Q4 2018 reduction was Vanguard S&P 500 Growth ETF, cutting an estimated $6.14M.
  • Corient Capital Partners fully exited AES in Q4 2018, selling an estimated $4.07M.
  • Corient Capital Partners's ten largest holdings make up 32% of its $561M portfolio in Q4 2018.
  • Corient Capital Partners opened 69 new positions and closed 28 in Q4 2018.
  • Corient Capital Partners's portfolio value fell 6.6% quarter-over-quarter to $561M.

Based on Corient Capital Partners's 13F filing for Q4 2018, filed 7 Feb 2019.